Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_assertion description "[Taken together, these results indicate that 2-DG enhances TRAIL-induced apoptosis in breast cancer cells by multiple mechanisms including suppression of RIP1, and highlight the potential therapeutic benefit of combinations of 2-DG and TRAIL in the treatment of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_assertion evidence source_evidence_literature NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_assertion SIO_000772 23499682 NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_assertion wasDerivedFrom befree-2016 NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_assertion wasGeneratedBy ECO_0000203 NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.
- befree-2016 importedOn "2016-02-19" NP1060966.RADQKcq2vUskRbupdJnmmZ57AJYSX_ax9Emkd2H8lXFyk130_provenance.